Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.890
-0.015 (-0.52%)
Nov 6, 2026, 4:00 PM EST - Market closed
Lexeo Therapeutics Employees
Lexeo Therapeutics had 63 employees as of June 30, 2026. The number of employees increased by 2 or 3.28% compared to the same quarter last year. That makes Lexeo Therapeutics the 33,948th largest employer in the world and 4,470th in the United States.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
n/a
Profits / Employee
-$1,385,159
Market Cap
237.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 63 | 2 | 3.28% |
| Mar 31, 2026 | 59 | -16 | -21.33% |
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Sep 30, 2025 | 61 | -11 | -15.28% |
| Jun 30, 2025 | 61 | -8 | -11.59% |
| Mar 31, 2025 | 75 | 17 | 29.31% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Sep 30, 2024 | 72 | 14 | 24.14% |
| Jun 30, 2024 | 69 | - | - |
| Dec 31, 2023 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Fate Therapeutics | 161 |
| AC Immune | 122 |
| Cartesian Therapeutics | 75 |
| Larimar Therapeutics | 71 |
| Immuneering | 65 |
LXEO News
- 6 days ago - Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November - GlobeNewsWire
- 10 days ago - Lexeo Therapeutics Registration statement: Registration filing - Filings
- 10 days ago - Lexeo Therapeutics files $300M mixed securities shelf - TheFly
- 18 days ago - Lexeo Therapeutics Transcript: Investor update - Transcripts
- 19 days ago - Lexeo Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 20 days ago - Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM - GlobeNewsWire
- 4 weeks ago - Lexeo Therapeutics to Participate in the Chardan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson's Disease and Movement Disorders 2026 (MDS) - GlobeNewsWire